Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07JLV
|
||||
Former ID |
DNC004051
|
||||
Drug Name |
Z-Ala-Leu-lle-Agly-Ile-Val-NHBzl
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [526417] | ||
Structure |
Download2D MOL |
||||
Formula |
C42H64N8O8
|
||||
Canonical SMILES |
CCC(C)C(C(=O)NC(C(C)C)C(=O)NCC1=CC=CC=C1)NC(=O)NNC(=O)C<br />(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC2=CC=CC=C2
|
||||
InChI |
1S/C42H64N8O8/c1-10-28(8)35(40(55)47-34(27(6)7)39(54)43-23-30-17-13-11-14-18-30)48-41(56)50-49-38(53)33(22-26(4)5)46-37(52)32(21-25(2)3)45-36(51)29(9)44-42(57)58-24-31-19-15-12-16-20-31/h11-20,25-29,32-35H,10,21-24H2,1-9H3,(H,43,54)(H,44,57)(H,45,51)(H,46,52)(H,47,55)(H,49,53)(H2,48,50,56)
|
||||
InChIKey |
XSXSYDVWNYPPNF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cathepsin B | Target Info | Inhibitor | [526417] | |
Cathepsin K | Target Info | Inhibitor | [526417] | ||
Reactome | Collagen degradation | ||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
MHC class II antigen presentation | |||||
WikiPathways | RANKL/RANK Signaling Pathway | ||||
Osteoclast Signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.